NuGene International Commences Trading Under Ticker NUGN

IRVINE, Calif., Feb. 6, 2015 /PRNewswire/ -- NuGene International (OTCQB:NUGN), the maker of age-defying aesthetic products for skin and hair rejuvenation developed from adult stem cells, has commenced trading under the ticker symbol NUGN. NuGene formulates, manufactures and distributes an advanced product line dedicated to regenerating, repairing and revitalize aging skin and hair. The company incorporates adult adipose human stem cell media and other active ingredients as the foundation of the formulation for its product lines.

The category of skincare products based on biotechnology, such as human stem cell, is just beginning to be developed. Nugene's goal is to leverage its knowledge of human stem cell applications and technology to develop and commercialize advanced anti-aging skin and hair care products principally for retail and professional channels.

Company Profile

NuGene International, Inc.
17912 Cowan Street
Irvine, CA  92614
Phone: (888) 327-4499
http://www.nugene.com/
[email protected]

Company Officers

M. Ali Kharazmi JD, MBA President & CEO

M. Saeed Kharazmi, M.D. Chairman of the Board, Director

Profile Data
SIC - Industry Classification         2844 – Cosmeceuticals
Incorporated In:               NV, USA
Year of Inc.         2006
Employees         12

Investor/ Media Relations:
Chris Rosgen
Capital Market Relations
(949)481-9739

Forward-Looking Statements

This release contains forward-looking statements. Actual results may differ from those projected due to a number of risks and uncertainties, including, but not limited to the possibility that some or all of the matters and transactions considered by NuGene International may not proceed as contemplated, and by all other matters and assumptions specified in NuGene's filings with the Securities and Exchange Commission, especially those risks and other matters described under "Risk Factors" within NuGene's Form 8-K filed with the Commission on January 6, 2015. These statements are made based upon current expectations that are subject to risk and uncertainty. NuGene does not undertake to update forward-looking statements in this news release to reflect actual results, changes in assumptions or changes in other factors affecting such forward-looking information.

Logo - http://photos.prnewswire.com/prnh/20150206/173947LOGO

SOURCE NuGene International